{
  "label": "clinical_signal_03_ep_003",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:f7717f742ab207de4172b6a6cccbd34d4b92f4ef7d31135025c1a0eafc15e02c",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:54:12.633935",
  "content": "## 2024-03-18 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 80\n- Active: 80\n- Screen Failures Cumulative: 5\n- Withdrawals Cumulative: 0\n\n#### Sites\n- Site 01 Enrolled: 8\n- Site 01 Active: 8\n- Site 01 Statin Concomitant: 2\n- Site 02 Enrolled: 6\n- Site 02 Active: 6\n- Site 02 Statin Concomitant: 1\n- Site 03 Enrolled: 7\n- Site 03 Active: 7\n- Site 03 Statin Concomitant: 1\n- Site 04 Enrolled: 5\n- Site 04 Active: 5\n- Site 04 Statin Concomitant: 1\n- Site 05 Enrolled: 6\n- Site 05 Active: 6\n- Site 05 Statin Concomitant: 1\n- Site 06 Enrolled: 4\n- Site 06 Active: 4\n- Site 06 Statin Concomitant: 1\n- Site 07 Enrolled: 8\n- Site 07 Active: 8\n- Site 07 Statin Concomitant: 2\n- Site 08 Enrolled: 6\n- Site 08 Active: 6\n- Site 08 Statin Concomitant: 1\n- Site 09 Enrolled: 6\n- Site 09 Active: 6\n- Site 09 Statin Concomitant: 1\n- Site 10 Enrolled: 5\n- Site 10 Active: 5\n- Site 10 Statin Concomitant: 1\n- Site 11 Enrolled: 7\n- Site 11 Active: 7\n- Site 11 Statin Concomitant: 1\n- Site 12 Enrolled: 6\n- Site 12 Active: 6\n- Site 12 Statin Concomitant: 1\n\n### Lab Panels\n#### Statin Subgroup\n- N: 55\n- ALT (U/L) Mean: 26.0\n- ALT (U/L) Median: 24.3\n- AST (U/L) Mean: 27.9\n- AST (U/L) Median: 25.9\n- Bilirubin (mg/dL) Mean: 0.59\n- Bilirubin (mg/dL) Median: 0.56\n- ALP (U/L) Mean: 79.3\n- ALP (U/L) Median: 57.2\n- Creatinine (mg/dL) Mean: 1.04\n- Creatinine (mg/dL) Median: 0.9\n- BUN (mg/dL) Mean: 16.6\n- BUN (mg/dL) Median: 14.8\n- WBC (K) Mean: 5.9\n- WBC (K) Median: 6.5\n- Platelets (K) Mean: 245\n- Platelets (K) Median: 220\n\n#### Non-Statin Subgroup\n- N: 124\n- ALT (U/L) Mean: 21.2\n- ALT (U/L) Median: 20.6\n- AST (U/L) Mean: 29.1\n- AST (U/L) Median: 28.2\n- Bilirubin (mg/dL) Mean: 0.54\n- Bilirubin (mg/dL) Median: 0.49\n- ALP (U/L) Mean: 73.5\n- ALP (U/L) Median: 63.4\n- Creatinine (mg/dL) Mean: 1.0\n- Creatinine (mg/dL) Median: 0.99\n- BUN (mg/dL) Mean: 17.2\n- BUN (mg/dL) Median: 14.5\n- WBC (K) Mean: 5.6\n- WBC (K) Median: 6.4\n- Platelets (K) Mean: 229\n- Platelets (K) Median: 240\n\n### Adverse Events\n- AE ID: AE-0008, Description: fatigue, Grade: 1, Relatedness: unlikely related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0009, Description: headache, Grade: 1, Relatedness: possibly related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0010, Description: fatigue, Grade: 1, Relatedness: unlikely related, Resolved: true, Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 51\n- ACE Inhibitor Count: 28\n- Metformin Count: 21\n- PPI Count: 19\n- NSAID Count: 13\n- Other Count: 32\n\n### Protocol Deviations\n- PD ID: PD-007, Description: Incorrect lab panel order, repeated, Severity: minor, Site: site_03\n- PD ID: PD-008, Description: Concomitant medication not recorded at visit, Severity: minor, Site: site_04\n\n### Investigator Notes\n- All CRFs current through prior visit cycle\n- Query resolution rate at 94%\n- Lab kits inventory adequate for next 4 weeks\n\n### Events\n- Central lab courier pickup schedule adjusted for holiday\n- Bioanalytical lab shipment tracking confirmed for 2 samples\n- Medical monitor weekly call completed\n\n### Notes\n- Week 3: Enrollment proceeding per plan. Lab panels within reference ranges. Routine AEs only.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_003",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-03-18T10:00:00",
    "phase": "baseline",
    "signal_density": "none",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}